Table 5.
Items | Wenxin Keli group (n = 600) | Placebo group (n = 600) |
---|---|---|
Abdominal discomfort | 0 | 1 (0.2) |
Gastrointestinal symptoms | 1 (0.2) | 1 (0.2) |
Headache | 1 (0.2) | 0 |
Dizziness | 1 (0.2) | 0 |
Palpitation | 0 | 1 (0.2) |
Osphyalgia | 0 | 1 (0.2) |
Total adverse events | 3 (0.5) | 4 (0.7) |
Withdrew due to Wenxin Keli | 0 | 1 (0.2) |